Acelyrin

Businessman puts his box of his belongs on the desk and holds a white letter
Biotech

Acelyrin loses interest in izokibep, lays off 3rd of staff

Despite maintaining its recent winning streak in the clinic, Acelyrin is no longer focused on its former lead asset izokibep.
Darren Incorvaia Aug 13, 2024 4:00pm
parachute sun mountain

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

May 10, 2024 8:30am
Two hands gripping onto a rope seemingly tugging in opposite directions

Acelyrin's proof-of-concept TED data cement Amgen challenge

Mar 20, 2024 7:00am
Photo of four hands going up for a rebound as a basketball floats above the rim

Acelyrin rebounds with psoriatic arthritis victory

Mar 11, 2024 10:59am
data error magnifying glass inspection mistake

Could a CRO error explain Acelyrin's shocking phase 3 failure?

Nov 28, 2023 5:00am
Rocky mountains snow

Gene editor Metagenomi adds C-suite execs—Chutes & Ladders

Nov 10, 2023 9:30am